Tapewire

Nasdaq · USD

KURA

Kura Oncology, Inc.

Export transactions ↓
Tapewire entity
4871
SEC CIK
0001422143
Parsed reports
239

Last 12 months

Inside the activity.

2 purchase rows · 31 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202502
Jan 2026016
Feb 202600
Mar 202600
Apr 202600
May 202604
Jun 202601
Jul 202600
Aug 202622
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2024 Filed Jan 4, 2024 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
GrantOption to purchase common stock · Derivative 560,000 $0.00 Strike: $15.36 $0.00
Disclosure

SEC source: 0000950170-24-001842 · ownership.xml · derivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 560,000

Underlying: Common Stock · 560,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
December 07, 2023 Filed Dec 11, 2023 21:08 UTC
WILSON TROY EDWARDDirector · President and CEO
GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-058040 · doc4.xml · nonDerivative · entry 2

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by One Fish Two Fish Revocable Trust

Disclosed balance after: 279,194

Read SEC document
December 07, 2023 Filed Dec 11, 2023 21:08 UTC
WILSON TROY EDWARDDirector · President and CEO
GiftCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-058040 · doc4.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 559

Read SEC document
August 14, 2023 Filed Aug 16, 2023 20:09 UTC
Powl Brian T.Chief Commercial Officer
GrantOption to purchase common stock · Derivative 200,000 $0.00 Strike: $11.72 $0.00
Disclosure

SEC source: 0001209191-23-046002 · doc4.xml · derivative · entry 1

Powl Brian T. · CIK 0001934232 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-08-13

F1 · derivative.exercise_date: 1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:29 UTC PurchaseCommon stock 50,000 $11.50 $575,000.00
Disclosure

SEC source: 0001209191-23-038797 · doc4.xml · nonDerivative · entry 1

Malley Thomas · CIK 0001403322 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Mossrock Capital, LLC

Disclosed balance after: 139,557

F1 · ownership.nature: Mr. Malley serves as President of Mossrock Capital, LLC and has sole voting and investment power over these shares.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 27,966 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033892 · doc4.xml · nonDerivative · entry 8

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,559

F2 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person. As a consequence of this transfer, the reporting person will no longer have beneficial ownership of the shares.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 300,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033892 · doc4.xml · nonDerivative · entry 7

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by Lorax Charitable Remainder Unitrust

Disclosed balance after: 300,000

F1 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 300,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033892 · doc4.xml · nonDerivative · entry 6

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by One Fish Two Fish Revocable Trust

Disclosed balance after: 280,194

F1 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 300,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033892 · doc4.xml · nonDerivative · entry 5

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by One Fish Two Fish Revocable Trust

Disclosed balance after: 580,194

F2 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person. As a consequence of this transfer, the reporting person will no longer have beneficial ownership of the shares.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 212,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033892 · doc4.xml · nonDerivative · entry 4

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by One Fish Two Fish Revocable Trust

Disclosed balance after: 880,194

F2 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person. As a consequence of this transfer, the reporting person will no longer have beneficial ownership of the shares.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 41,318 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033892 · doc4.xml · nonDerivative · entry 3

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by One Fish Two Fish Revocable Trust

Disclosed balance after: 1,092,694

F2 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person. As a consequence of this transfer, the reporting person will no longer have beneficial ownership of the shares.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 8,394 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033892 · doc4.xml · nonDerivative · entry 2

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by One Fish Two Fish Revocable Trust

Disclosed balance after: 1,134,012

F1 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 8,394 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033892 · doc4.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · by Red Fish Blue Fish Revocable Trust

Disclosed balance after: 0

F1 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 21:02 UTC
Szela Mary TDirector
GrantOption to purchase common stock · Derivative 26,000 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001209191-23-033888 · doc4.xml · derivative · entry 1

Szela Mary T · CIK 0001410289 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2033-05-30

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 20:57 UTC GrantOption to purchase common stock · Derivative 26,000 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001209191-23-033871 · doc4.xml · derivative · entry 1

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2033-05-30

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 21:00 UTC GrantOption to purchase common stock · Derivative 26,000 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001209191-23-033879 · doc4.xml · derivative · entry 1

SCHAFER CAROL · CIK 0001272181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2033-05-30

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 20:53 UTC GrantOption to purchase common stock · Derivative 26,000 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001209191-23-033859 · doc4.xml · derivative · entry 1

Malley Thomas · CIK 0001403322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2033-05-30

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 20:49 UTC GrantOption to purchase common stock · Derivative 26,000 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001209191-23-033850 · doc4.xml · derivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2033-05-30

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 20:45 UTC GrantOption to purchase common stock · Derivative 26,000 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001209191-23-033836 · doc4.xml · derivative · entry 1

Collins Helen Louise · CIK 0001701247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires 2033-05-30

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:13 UTC
Bair Teresa BrophyChief Legal Officer
GrantOption to purchase common stock · Derivative 138,750 $0.00 Strike: $11.99 $0.00
Disclosure

SEC source: 0001209191-23-011287 · doc4.xml · derivative · entry 2

Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,750

Underlying: Common Stock · 138,750 shares

Expires 2033-02-15

F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:13 UTC
Bair Teresa BrophyChief Legal Officer
GrantCommon Stock 23,125 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011287 · doc4.xml · nonDerivative · entry 1

Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,125

F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/24, 1/26/25, 1/26/26 and 1/26/27.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:15 UTC
DOYLE THOMAS JAMESSVP, Finance & Accounting
GrantOption to purchase common stock · Derivative 63,750 $0.00 Strike: $11.99 $0.00
Disclosure

SEC source: 0001209191-23-011289 · doc4.xml · derivative · entry 3

DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,750

Underlying: Common Stock · 63,750 shares

Expires 2033-02-15

F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:15 UTC
DOYLE THOMAS JAMESSVP, Finance & Accounting
GrantCommon Stock 10,625 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011289 · doc4.xml · nonDerivative · entry 1

DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,466

F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/24, 1/26/25, 1/26/26 and 1/26/27.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:11 UTC
FORD KATHLEENChief Operating Officer
GrantOption to purchase common stock · Derivative 185,000 $0.00 Strike: $11.99 $0.00
Disclosure

SEC source: 0001209191-23-011285 · doc4.xml · derivative · entry 1

FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,000

Underlying: Common Stock · 185,000 shares

Expires 2033-02-15

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:08 UTC
DALE STEPHENChief Medical Officer
GrantOption to purchase common stock · Derivative 185,000 $0.00 Strike: $11.99 $0.00
Disclosure

SEC source: 0001209191-23-011283 · doc4.xml · derivative · entry 2

DALE STEPHEN · CIK 0001821709 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,000

Underlying: Common Stock · 185,000 shares

Expires 2033-02-15

F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:08 UTC
DALE STEPHENChief Medical Officer
GrantCommon Stock 23,125 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011283 · doc4.xml · nonDerivative · entry 1

DALE STEPHEN · CIK 0001821709 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,800

F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/24, 1/26/25, 1/26/26 and 1/26/27.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:04 UTC
WILSON TROY EDWARDDirector · President and CEO
GrantOption to purchase common stock · Derivative 560,000 $0.00 Strike: $11.99 $0.00
Disclosure

SEC source: 0001209191-23-011276 · doc4.xml · derivative · entry 8

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 560,000

Underlying: Common Stock · 560,000 shares

Expires 2033-02-15

F4 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 22:17 UTC
FLOWERS KIRSTENCCO & Chief Strategy Officer
SaleCommon Stock 1,906 $13.89 $26,474.34
Disclosure

SEC source: 0001209191-23-005748 · doc4.xml · nonDerivative · entry 1

FLOWERS KIRSTEN · CIK 0001797209 · CCO & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,605

F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 22:20 UTC
FORD KATHLEENChief Operating Officer
SaleCommon Stock 1,821 $13.89 $25,293.87
Disclosure

SEC source: 0001209191-23-005753 · doc4.xml · nonDerivative · entry 1

FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,214

F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 22:10 UTC
DALE STEPHENChief Medical Officer
SaleCommon Stock 4,840 $13.87 $67,124.02
Disclosure

SEC source: 0001209191-23-005744 · doc4.xml · nonDerivative · entry 2

DALE STEPHEN · CIK 0001821709 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,675

F3 · price: This transaction was executed in multiple trades at prices ranging from $13.62 to $14.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · acquired: This transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2022.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 22:10 UTC
DALE STEPHENChief Medical Officer
SaleCommon Stock 4,385 $13.89 $60,908.97
Disclosure

SEC source: 0001209191-23-005744 · doc4.xml · nonDerivative · entry 1

DALE STEPHEN · CIK 0001821709 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,515

F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 22:14 UTC
DOYLE THOMAS JAMESSVP, Finance & Accounting
SaleCommon Stock 866 $13.89 $12,028.91
Disclosure

SEC source: 0001209191-23-005746 · doc4.xml · nonDerivative · entry 2

DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,841

F3 · acquired: Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 2/7/22.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 22:14 UTC
DOYLE THOMAS JAMESSVP, Finance & Accounting
SaleCommon Stock 682 $13.89 $9,472.84
Disclosure

SEC source: 0001209191-23-005746 · doc4.xml · nonDerivative · entry 1

DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,707

F1 · acquired: Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 1/26/22.

F2 · balance_after: Includes 1,806 shares acquired on May 17, 2022 and 1,583 shares acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
November 17, 2022 Filed Nov 18, 2022 21:53 UTC
Bair Teresa BrophyChief Legal Officer
SaleCommon Stock 2,100 $15.22 $31,964.52
Disclosure

SEC source: 0001209191-22-057874 · doc4.xml · nonDerivative · entry 1

Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2022.

F2 · shares: 2,100 shares were acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $15.08 to $15.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 06, 2022 Filed Feb 21, 2023 22:04 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 1,084,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011276 · doc4.xml · nonDerivative · entry 6

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by One Fish Two Fish Revocable Trust

Disclosed balance after: 1,125,618

F2 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another grantor trust established by the reporting person.

Read SEC document
October 06, 2022 Filed Feb 21, 2023 22:04 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 1,084,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011276 · doc4.xml · nonDerivative · entry 5

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by Red Fish Blue Fish Revocable Trust

Disclosed balance after: 8,394

F2 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another grantor trust established by the reporting person.

Read SEC document
August 19, 2022 Filed Feb 21, 2023 22:04 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 11,985 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011276 · doc4.xml · nonDerivative · entry 7

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,525

F1 · kind: Shares were transferred to the reporting person's former spouse pursuant to a divorce settlement. The securities owned by the former spouse are not beneficially owned by the reporting person.

F3 · balance_after: Includes 1,109 shares acquired on November 17, 2021 and 1,450 shares acquired on May 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
August 19, 2022 Filed Feb 21, 2023 22:04 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 41,318 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011276 · doc4.xml · nonDerivative · entry 4

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by One Fish Two Fish Revocable Trust

Disclosed balance after: 41,318

F2 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another grantor trust established by the reporting person.

Read SEC document
August 19, 2022 Filed Feb 21, 2023 22:04 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 41,318 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011276 · doc4.xml · nonDerivative · entry 3

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by Red Fish Blue Fish Revocable Trust

Disclosed balance after: 1,092,694

F2 · kind: This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another grantor trust established by the reporting person.

Read SEC document
August 19, 2022 Filed Feb 21, 2023 22:04 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 17,708 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011276 · doc4.xml · nonDerivative · entry 2

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by Red Fish Blue Fish Revocable Trust

Disclosed balance after: 1,134,012

F1 · kind: Shares were transferred to the reporting person's former spouse pursuant to a divorce settlement. The securities owned by the former spouse are not beneficially owned by the reporting person.

Read SEC document
July 14, 2022 Filed Feb 21, 2023 22:04 UTC
WILSON TROY EDWARDDirector · President and CEO
OtherCommon Stock 468,297 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011276 · doc4.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by Red Fish Blue Fish Revocable Trust

Disclosed balance after: 1,151,720

F1 · kind: Shares were transferred to the reporting person's former spouse pursuant to a divorce settlement. The securities owned by the former spouse are not beneficially owned by the reporting person.

Read SEC document
June 21, 2022 Filed Jun 23, 2022 20:47 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $14.84 $0.00
Disclosure

SEC source: 0001209191-22-038922 · doc4.xml · derivative · entry 1

Stein Steven H · CIK 0001673776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2032-06-20

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 21, 2022 Filed Jun 23, 2022 20:54 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $14.84 $0.00
Disclosure

SEC source: 0001209191-22-038944 · doc4.xml · derivative · entry 1

Collins Helen Louise · CIK 0001701247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2032-06-20

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 21, 2022 Filed Jun 23, 2022 20:53 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $14.84 $0.00
Disclosure

SEC source: 0001209191-22-038936 · doc4.xml · derivative · entry 1

SCHAFER CAROL · CIK 0001272181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2032-06-20

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 21, 2022 Filed Jun 23, 2022 20:52 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $14.84 $0.00
Disclosure

SEC source: 0001209191-22-038931 · doc4.xml · derivative · entry 1

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2032-06-20

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 21, 2022 Filed Jun 23, 2022 20:49 UTC
Szela Mary TDirector
GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $14.84 $0.00
Disclosure

SEC source: 0001209191-22-038926 · doc4.xml · derivative · entry 1

Szela Mary T · CIK 0001410289 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2032-06-20

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 21, 2022 Filed Jun 23, 2022 20:46 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $14.84 $0.00
Disclosure

SEC source: 0001209191-22-038917 · doc4.xml · derivative · entry 1

Malley Thomas · CIK 0001403322 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2032-06-20

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 21, 2022 Filed Jun 23, 2022 20:44 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $14.84 $0.00
Disclosure

SEC source: 0001209191-22-038913 · doc4.xml · derivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2032-06-20

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
February 07, 2022 Filed Feb 9, 2022 22:50 UTC
DOYLE THOMAS JAMESSVP, Finance & Accounting
GrantOption to purchase common stock · Derivative 39,281 $0.00 Strike: $13.14 $0.00
Disclosure

SEC source: 0001209191-22-008156 · doc4.xml · derivative · entry 3

DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,281

Underlying: Common Stock · 39,281 shares

Expires 2032-02-06

F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
February 07, 2022 Filed Feb 9, 2022 22:50 UTC
DOYLE THOMAS JAMESSVP, Finance & Accounting
GrantCommon Stock 8,390 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-008156 · doc4.xml · nonDerivative · entry 1

DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.